Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 147 and 368 of Human FLJ10808|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-30675 targets FLJ10808 in WB applications and shows reactivity with Human samples.
The PA5-30675 immunogen is recombinant fragment corresponding to a region within amino acids 147 and 368 of Human FLJ10808.
Modification of proteins with ubiquitin (UBB; MIM 191339) or ubiquitin-like proteins controls many signaling networks and requires a ubiquitin-activating enzyme (E1), a ubiquitin conjugating enzyme (E2), and a ubiquitin protein ligase (E3). UBE1L2 is an E1 enzyme that initiates the activation and conjugation of ubiquitin-like proteins (Jin et al., 2007 [PubMed 17597759]).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
E1-L2; monocyte protein 4; MOP-4; UBA6; UBA6, ubiquitin-activating enzyme E1; UBE1L2; ubiquitin-activating enzyme 6; ubiquitin-activating enzyme E1; ubiquitin-activating enzyme E1-like 2; ubiquitin-activating enzyme E1-like protein 2; ubiquitin-like modifier activating enzyme 6; ubiquitin-like modifier-activating enzyme 6
E1-L2; MOP-4; MOP4; UBA6; UBE1L2